POINT BIOPHARMA GLOBAL INC. Proceeds from Notes Payable
POINT BIOPHARMA GLOBAL INC. reported Proceeds from Notes Payable of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2022-03-25
- POINT BIOPHARMA GLOBAL INC. proceeds from notes payable for the quarter ending 2020-12-31 was $0.00.
- POINT BIOPHARMA GLOBAL INC. proceeds from notes payable for fiscal 2020 was $3.55M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $3.55M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $3.55M 10-Q · filed 2021-11-12 |